All News

Bloomington, IN-Cook Medical has developed the BIGopsy biopsy forceps that capture specimens of sufficient size to produce accurate biopsy results without need for additional samples. The forceps' oversized jaw design and patented backloading handle obtain specimens up to four times larger than those available with traditional forceps, and the 2.4F sheath offers greater flow than do standard 3F sheaths.

With rising health care costs and the increasing expense of the robotic platform, many believe that robotic prostatectomy must prove superior to its open counterpart in some way other than convalescence alone.

Injection of a gene therapy vector in rats with erectile dysfunction enabled the return of normal function within 4 weeks, according to a study from the University of Pittsburgh School of Medicine. The research may be the first step in developing a new mode of long-term ED treatment, researchers say.

Treatment failure in patients at high risk for prostate cancer is primarily local, with a markedly low metastatic failure incidence, researchers from the Southwest Oncology Group recently reported. Further, at all postsurgical PSA levels, additional radiation to the prostate bed lowers metastatic disease risk and biochemical failure.

For patients with localized prostate cancer, the type of specialist seen may affect the type of therapy they receive, according to a study from Memorial Sloan-Kettering Cancer Center. Specifically, men between the ages of 65 to 69 years who see a urologist would have a greater likelihood of undergoing prostate surgery, but those who consult both a radiation oncologist and a urologist- regardless of age-would likely receive radiation therapy.

Urologist Freddy A. Camuzzi, MD, 60, of Largo, FL, died when the single-engine airplane he was piloting crashed at a remote mountain airstrip in North Carolina. Charles R. "Chas" Freeble, III, MD, 59, a St. Petersburg, FL, cardiologist and internist, and Kathleen Campbell Freeble, 59, Dr. Freeble's wife, were also killed in the crash, the St. Petersburg Times reported.

During the month of June, which is Men's Health Month, the Erectile Dysfunction Institute is encouraging all men who experience erectile dysfunction to discuss their symptoms with visits to their physicians.

A pre-treatment rate of PSA velocity of more than 2.0 ng/mL per year is strongly associated with a high risk of death from prostate cancer, a study to be published in the July 1 issue of Cancer suggests. Elevated PSA velocity was a stronger poor prognostic factor than any other single high-risk indicator, such as a biopsy Gleason score greater than 7, a PSA level of 10.0 ng/mL, or an advanced disease category.

While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced prostate cancers, according to a study in the Journal of the National Cancer Institute (2007; 99:754-64).

Dendreon Corp. said it has received confirmation that the FDA will accept either a positive interim or final analysis of survival from its ongoing IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) study to amend the biologics license application (BLA) for sipuleucel-T (Provenge), a form of immunotherapy in late-stage development for the treatment of hormone-refractory prostate cancer.

Sex is important to men and women worldwide, according to findings from a large global survey, yet a significant proportion of men and women are not completely satisfied with their sex lives.

Results from a recent study that systematically analyzed the data of placebo-controlled trials in patients with BPH confirm that BPH is a progressive disease on the basis of worsening prostate volume, maximum urinary flow, and symptom score, as well as the rate of prostate-related surgery and acute urinary retention.